DHCA markedly alters the transcriptional landscape in rat kidney tissues. Hub genes and pathways related to inflammation and apoptosis may constitute central pathogenic mechanisms and represent promising therapeutic targets for DHCA-AKI.
Wang et al. (Tue,) studied this question.